Transfusion support for patients with sickle cell disease

Area of Science:

• Hematology
• Transfusion Medicine
• Sickle Cell Disease Management

Background:

• Sickle cell disease (SCD) involves red blood cells (RBCs) with abnormal hemoglobin S (HbS).
• RBC transfusions are a cornerstone therapy for SCD, aiming to increase oxygen transport and decrease HbS levels.
• Elevated HbS contributes to vaso-occlusive events, a hallmark of SCD pathology.

Purpose of the Study:

• To review the critical role and various strategies of RBC transfusion in managing sickle cell disease.
• To highlight the importance of transfusion goals, methods, vascular access, and blood bank considerations in SCD care.
• To discuss the application of transfusions in both acute and chronic SCD management and prevention.

Main Methods:

• Review of current transfusion practices for sickle cell disease.
• Discussion of simple RBC transfusion versus RBC exchange (manual and automated).
• Consideration of vascular access options and blood bank protocols for antigen matching.

Main Results:

• Simple transfusion corrects anemia and reduces HbS without RBC removal.
• Partial manual RBC exchange allows greater HbS reduction than simple transfusion.
• Automated RBC exchange (apheresis) provides rapid, drastic HbS reduction for critical situations.
• Adequate vascular access (peripheral, central, or implantable) is crucial for effective transfusion therapy.
• RBC antigen matching is essential to prevent alloimmunization in SCD patients.
• Transfusions are effective in managing acute SCD complications (stroke, anemia, chest syndrome) and for chronic prevention (stroke, pregnancy, surgery).

Conclusions:

• RBC transfusion is a versatile and essential therapeutic modality for sickle cell disease.
• The choice of transfusion method and management of access and blood bank issues must be individualized.
• Ongoing evaluation of transfusion guidelines and clinical indications is necessary for optimizing SCD patient care.